Correction to: NMDA antagonists under investigation for the treatment of major depressive disorder
Pochwat B, Pałucha-Poniewiera A, Szewczyk B, Pilc A & Nowak G. NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin. Investig. Drugs 2014;23(9):1181-92.
Following publication of this article, an error was identified on page 1184 in the following sentence:
Instead, it was shown that a crucial cellular event responsible for NMDARs’ antagonist antidepressant-like activity may be activation of eukaryotic elongation factor 2 kinase (eEF2K) inducing an intensified transcription of numerous proteins, including BDNF [39].
The correct sentence is:
Instead, it was shown that a crucial cellular event responsible for NMDARs’ antagonist antidepressant-like activity may be activation of eukaryotic elongation factor 2 kinase (eEF2K) inducing an intensified translation of numerous proteins, including BDNF [39].